Global X Defense Tech ETF vs 22nd Century Group Inc — how do they compare? Global X Defense Tech ETF trades at $61.96, while 22nd Century Group Inc trades at $2.17 (market cap $1.50M). The key difference: Global X Defense Tech ETF is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals.
| SHLD | XXII | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $78.02 | $594.00 |
52-Week Low | $58.20 | $2.13 |
Market Cap | — | $1.50M |
Enterprise Value | — | -$2.81M |
Signals from Pluang's Aura AI — not financial advice
SHLD trades at $62.72, down 0.41% today, with a bearish technical signal from moving averages but bullish oscillators like RSI near oversold levels. The ETF focuses on global defense technology, benefiting from rising military spending trends. Recent news highlights institutional buying interest and geopolitical tailwinds, though financial ratios are currently unavailable for detailed valuation.
The outlook for SHLD is supported by global defense budget increases and diversified tech exposure, but risks include ETF expense comparisons and market volatility. Analyst sentiment is mixed, with some advocating for rebound potential given current support levels and long-term growth prospects in the defense sector.
XXII trades at $2.29, down 4.58% today, with a bearish technical signal from moving averages but oversold RSI readings. The company reported a Q2 2026 EPS miss of -15.6 versus -6 expected, with negative gross and net income margins. Recent news highlights VLN brand expansion and a 20:1 reverse stock split effective June 12, 2026.
Outlook is challenged by persistent losses and high cash burn, though analyst consensus is 75% buy. Key risks include execution on commercialization and profitability turnaround. The stock's low valuation multiples may attract speculative interest if operational improvements materialize.
Trailing returns across standard periods
SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →